Effect of Premedicant Oral Paracetamol on Gastric Volume and pH

February 18, 2021 updated by: King's College Hospital NHS Trust

A Randomised Controlled Trial Examining the Effect of Premedicant Oral Paracetamol on Gastric Residual Volume and pH in Children, in the Context of a 1-hour Clear Fluid Fast

Patients are asked to fast before general anaesthesia to reduce the risk that any gastric contents could be regurgitated and aspirated into the lungs once anaesthetised. If aspiration does occur, the volume and acidity of the fluid aspirated are thought to determine the extent of any harm caused. Recent guidelines have reduced the required fasting time for children for clear fluids from 2 hours to 1 hour before induction of anaesthesia, as it is understood that this does not adversely affect the gastric residual volume or increase its acidity. Paracetamol is commonly used to relieve pain during and after surgery. Paracetamol syrup preparations used in children are viscous and not classified as clear fluid. This study seeks to establish whether there is non-inferiority in gastric residual volume (GRV) and pH in children receiving oral paracetamol one hour before induction of anaesthesia and those who do not, when both groups have received a set volume of diluted orange cordial to drink. It is anticipated that if shown to have little or no impact on GRV and pH, oral paracetamol syrup can be given to children before surgery. This will omit the need for IV paracetamol to be given in theatre, potentially reducing cost and the risk of drug errors.

Study Overview

Status

Recruiting

Conditions

Detailed Description

Patients are asked to fast before anaesthesia to reduce the risk that residual gastric contents could be regurgitated and aspirated into the lungs once anaesthetised. In animal studies, gastric contents that are less acidic (with a pH >1.8) have been shown to be less harmful when aspirated than those that are more acidic, even at higher gastric residual volumes. Recent European and UK guidelines have reduced the length of the recommended clear fluid fast to 1 hour for children, as there is no significant difference in GRV or pH in children fasted for 1 hour compared to 2 hours. It is therefore believed to present no additional risk of harm.

Some anaesthetists administer oral paracetamol syrup to children pre-operatively as an alternative to intravenous administration of paracetamol during their surgery. The oral route has been suggested to be pleasant for children, cheaper, more convenient, and reduce the risk of drug errors associated with the IV preparation. Anderson et al found no significant difference in gastric volume or pH in children with a mean age of 8.5 years given paracetamol orally 90 minutes before surgery compared to children given paracetamol rectally. Burke et al. demonstrated that giving paracetamol orally up to 8 minutes before induction of anaesthesia was not associated with an increase in the volume of stomach contents, and that the pH of stomach contents was higher than in control subjects who did not receive paracetamol. This suggests that giving oral paracetamol before induction of anaesthesia may not present any increased risk of harm from aspiration. This was in the context of a mean fluid fast of 5 hours and a mean age of 5.1 years.

To our knowledge, no studies have assessed the effect of oral paracetamol syrup on gastric residual volume (GRV) and pH in the context of the newly recommended reduced clear fluid fasting time of 1 hour. Neither has this been studied in children as young as 44 weeks post-conceptual age.

Study Type

Interventional

Enrollment (Anticipated)

104

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 months to 8 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Elective surgery
  • Requiring tracheal intubation for general anaesthesia
  • Parent/guardian able to speak and understand written English

Exclusion Criteria:

  • Known or suspected gastro-intestinal disease including varices
  • Previous surgery which may alter gastric emptying or the anatomy of the oesophagus or stomach
  • Anticipated difficult airway
  • Concomitant administration of any other medication orally prior to anaesthesia, but excluding buccal sedative pre-medication eg midazolam
  • Bleeding disorders
  • Patients taking antacids or pro-kinetic drugs, or requiring them pre-operatively
  • Allergy to paracetamol
  • Patient weight greater than 25 kg
  • Parental or patient refusal

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Standard care
Participants in this arm shall receive 3.6 ml/kg of water a minimum of 1 hour prior to the induction of general anaesthesia. This is standard practice in the 2 participating institutions.
Standard care of 3.6 ml/kg water, a minimum of 1 hour prior to the induction of general anaesthesia.
Experimental: Paracetamol arm
Participants in this arm shall receive 3 ml/kg of water plus 15 mg/kg of oral paracetamol suspension a minimum of 1 hour prior to the induction of general anaesthesia.
Standard care of 3 ml/kg water, plus 15 mg/kg oral paracetamol suspension, a minimum of 1 hour prior to the induction of general anaesthesia.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Residual volume of gastric contents following induction of general anaesthesia
Time Frame: Approximately 5-10 minutes following the induction of general anaesthesia.
Gastric volume and pH of that fluid that can be aspirated via an oro-gastric tube, passed into the patient's stomach once general anaesthesia has been induced and the airway secured.
Approximately 5-10 minutes following the induction of general anaesthesia.
pH of gastric contents following induction of general anaesthesia
Time Frame: Approximately 5-10 minutes following the induction of general anaesthesia.
Gastric volume and pH of that fluid that can be aspirated via an oro-gastric tube, passed into the patient's stomach once general anaesthesia has been induced and the airway secured.
Approximately 5-10 minutes following the induction of general anaesthesia.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adverse events at induction of anaesthesia
Time Frame: Up to 10 minutes after the induction of anaesthesia
Adverse events occurring around the time of induction of anaesthesia including regurgitation and aspiration of gastric contents
Up to 10 minutes after the induction of anaesthesia
Adverse events at emergence from anaesthesia
Time Frame: Up to 10 minutes from removal of the patient's airway
Adverse events occurring around the time of emergence from anaesthesia including regurgitation and aspiration of gastric contents
Up to 10 minutes from removal of the patient's airway
Paracetamol drug errors
Time Frame: For day case patients, until discharge. For inpatients, up to 24 hours post-operatively.
Paracetamol related drug errors
For day case patients, until discharge. For inpatients, up to 24 hours post-operatively.
Emergence delirium
Time Frame: Up to 10 minutes following patient arrival in PACU.
Incidence of emergence delirium in post-anaesthesia care unit, measured with PAED score.
Up to 10 minutes following patient arrival in PACU.
Adverse events in Post-Anaesthesia Care Unit
Time Frame: From arrival in the post-anaesthesia care unit until patient is ready for discharge to the ward, up to 24 hours.
Adverse regurgitation or aspiration events occurring in the post-anaesthesia care unit, including requirements for additional analgesia, time to first analgesic request and time spent in the post-anaesthesia care unit.
From arrival in the post-anaesthesia care unit until patient is ready for discharge to the ward, up to 24 hours.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Emily Saffer, MB BS, King's College Hospital NHS Trust

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 6, 2020

Primary Completion (Anticipated)

August 1, 2021

Study Completion (Anticipated)

December 1, 2021

Study Registration Dates

First Submitted

July 29, 2020

First Submitted That Met QC Criteria

November 10, 2020

First Posted (Actual)

November 12, 2020

Study Record Updates

Last Update Posted (Actual)

February 21, 2021

Last Update Submitted That Met QC Criteria

February 18, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fasting

Clinical Trials on Standard care

3
Subscribe